1 / 29

Acute Stroke: New Treatment Concepts

Richard Leigh, M.D. Johns Hopkins University School of Medicine. Acute Stroke: New Treatment Concepts. Stroke Neurology. Training Medical Internship Neurology Residency Vascular Neurology Fellowship Inpatient Stroke Service Stroke Unit Telemetry Specialized nursing

dane
Download Presentation

Acute Stroke: New Treatment Concepts

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Richard Leigh, M.D. Johns Hopkins University School of Medicine Acute Stroke: New Treatment Concepts

  2. Stroke Neurology • Training • Medical Internship • Neurology Residency • Vascular Neurology Fellowship • Inpatient Stroke Service • Stroke Unit • Telemetry • Specialized nursing • Acute Stroke Treatment

  3. Ischemic Stroke • Different than hemorrhagic stroke in cause treatment and prevention. • Broadly divided into: • Small vessel • Lacunar • Embolic • Cardioembolic • Large Artery-to-Artery Embolic • Cryptogenic • Hypercoagulable • Cancer • Primary Hypercoagulability

  4. Ischemic Stroke Management • Diagnosis/Intervention • Save The Brain • Hospital Admission and Work-up • Secondary Prevention • Rehabilitation • Recovery

  5. Acute Treatment Time Is Brain!

  6. Time = Disability Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. KhatriP, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA; IMS I and II Investigators. Neurology. 2009 Sep 29;73(13):1066-72. doi: 10.1212/WNL.0b013e3181b9c847.

  7. Acute Treatment • IV thrombolytics • tPA (Alteplase) – only FDA approved treatment • Desmotoplase (Currently in Clinical Trial) • Endovascular Recanalization • IA tPA • Mechanical Thrombectomy • Induced or Permissive Hypertension • Fluids • Pressors • Heparin? • No, Heparin is secondary prevention for some patients

  8. IV Thrombolysis • 3 hrs from symptom onset or last seen normal • HCT negative for acute disease • Blood • Hypodensity • Labs • INR if they take warfarin or have liver disease • INR>1.7 is an exclusion • Plts/glucose • Historical Contraindications • BP limits

  9. IV Thrombolysis - Myths • NIH stroke scale (NIHSS) cutoff? • There is none! • What is required: • “Quantifiable Neurologic Deficit” • Potentially disabling deficit • ASA/plavix exclusion? • No! • Age restriction? • No! -> not in the 3hr window • Rapidly improving symptoms? • Be careful – fluctuating vs. improving symptoms are tough to distinguish

  10. IV Thrombolysis • 3-4.5 hrs from symptom onset or last seen normal • Extra exclusions: • Age>80 • On coumadin (regardless of INR) • History of Diabetes and Stroke • Otherwise identical to 3 hour window

  11. Treatment Beyond 4.5 Hours • Currently no approved treatments • IA Therapy • Unproven • MRI based selection for IV Therapy: No tPA IV tPA

  12. IA Therapy • Controversial • Has not been validated in a clinical trial • Some would say it has been disproven (MR Rescue) • Routinely done at large medical centers • Patient Selection Methods • Penumbra DWI/PWI mismatch • Malignant Profile • Time based

  13. DWI ADC PWI FLAIR • Volumetrics : • DWI volume of 13cc • 6 sec PWI deficit of 67cc • 10sec PWI deficit of 40cc • Mismatch Ratio 5.15

  14. IA Therapies • IA tPA • Lower dose delivered directly to the clot • Only recommended within 6 hours of onset • Mechanical Thrombectomy • Stentriever • Suction devices • Older devices out of favor (corkscrew, ultrasound)

  15. IV/IA Combo Therapy • IMS 3 – multicenter randomized trial • Stopped early due to lack of benefit • Drip-and-Ship Model • Start the IV tPA at a community hospital and then transport the patient for IA therapy at a stroke center • This practice essentially ended with IMS 3

  16. Hypertensive Therapy • Permissive HTN • Essentially done in all stroke patients • Let them auto-hypertense • Induced HTN • Need to document a pressure dependent exam • Start with fluids (always NS, never hypotonics) • May need ICU for pressors • Can be transitioned to midodrine or florinef • But don’t hypertense them for ever!

  17. 2 4 6 8 TTP thresholds in seconds Before induced hypertension

  18. 2 4 6 8 TTP thresholds in seconds After induced hypertension

  19. Secondary Prevention • The Default Secondary prevention is: • ASA 325mg • Anticoagulation must be earned! • Statin • High dose, High potency • Goal LDL<70 • HTN • ACE inhibitors first line • Diuretics are last line • Diabetes Management • Smoking Cessation • Diet/Excersize

  20. Dual Therapy – ASA+Plavix • MATCH Trial • plavix vs. ASA/plavix • 18 months • Bleeding out weighed any benefit • SAMMPRIS Trial • Stenting vs maximal medical therapy for symptomatic intracranial stenosis. • 3 months of ASA/plavix showed clear benefit over not only stenting but also ASA alone • CHANCE Trial • ASA/Plavix for 1 month after minor stroke or TIA • Effective an a Chinese population • POINT trial ongoing

  21. Anticoagulation Indications • A-fib • 24 hours of in house telemetry • Cryptogenic stroke patents (whose stroke is embolic appearing on MRI) will wear a 30 day event monitor as an outpatient • When to start anticoagulation if in afib? • Small strokes, right away • Big strokes wait a month • ASA to coumadin bridge • Rapid recurrent stroke in afib happens but is not common • Cardiac thrombus on echo changes the equation • ASA+Plavix for Afib -> Active-A trial

  22. Anticoagulation Indications • Echocardiogram • TTE vs TEE • Level of suspicion for cardiac source • Looking for • Cardiac thrombus • Left atrial dilitation • Ejection fraction • WARCEF –> EF<35% benefits from coumadin at 4 years • PFO – bubble study • Controversial role in stroke

  23. Anticoagulation Indications • Dissection • ASA or Coumadin are acceptable treatments • Data suggests recurrent stroke after dissection is rare. • Typical management is 3-6 months of anticoagulation. • Cerebral Sinus Thrombosis • Venous stroke due to hypercoagulable state • 3-6 months of anticoagulation unless it is a primary hypercoagulable state

  24. Extracranial Carotid Artery Stenosis • Screening for CAS typically done with ultrasound • Velocity measures of >70% stenosis generally considered treatable if symptomatic • Stenosis found on ultrasound should be confirmed with CTA/MRA/angiogram • Stenosis of <70% can be symptomatic • Consider vessel wall imaging • Asymptomatic stenosis should be treated medically. • Keep in mind that the NACET trial was done in the pre-statin era

  25. Extracranial Carotid Artery Stenosis • Symptomatic carotid artery stenosis should be treated urgently. • Carotid Endarterectomy (CEA) vs. Carotid Artery Stenting (CAS) • Generally felt to be equivalent treatments • Operator dependent • If going for CEA, start heparin (if stroke not too big) • If going for CAS, start ASA/plavix

  26. Stroke Recovery • We can prevent stroke • We can treat stroke • Can we affect recovery? • PT/OT/SLP • Why do some patients recover completely and others not at all?

  27. Stroke Recovery • General Principles in Stroke Recovery • Strokes get better • Most of the recovery is in the first month but patients can keep recovering for up to a year • Younger healthier brains recovery better • Rapid improvement in the hospital is a good prognostic sign

  28. Stroke Recovery • Newer thinking in stroke recovery: • Some patients have a predisposition to recover • There appears to be a window of recovery which is opened by the stroke • Early intervention may be the key • How can we open/extend the window? • SSRIs seem promising • FLAME trial – Prozac and Motor recovery • Lexapro in cognitive recovery after stroke

  29. The Future of Stroke • Acute Treatement: • Individualized care • More IV therapies • Secondary Prevention • Early aggressive treatment with taper • Recovery • SSRIs

More Related